Gene · 3695
Papers1,437
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,437
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Improving the performance of single-cell RNA-seq data mining based on relative expression orderings. | Brief Bioinform | 2023 | 36528803 | PubTator, text mining | PubMed |
| Dysfunctional Extracellular Matrix Remodeling Supports Perianal Fistulizing Crohn's Disease by a Mechanoregulated Activation of the Epithelial-to-Mesenchymal Transition. | Cell Mol Gastroenterol Hepatol | 2023 | 36521659 | PubTator, text mining | PubMed |
Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study. | Inflamm Bowel Dis | 2023 | 36378498 | PubTator, text mining | PubMed |
| The Notch1/CD22 signaling axis disrupts Treg function in SARS-CoV-2-associated multisystem inflammatory syndrome in children. | J Clin Invest | 2023 | 36282598 | PubTator, text mining | PubMed |
| Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety. | Cancer Discov | 2023 | 36259971 | PubTator, text mining | PubMed |
| Association of gut-specific non-inflammatory T lymphocytes with chronic anorexia nervosa and constitutional thinness. | Eur Eat Disord Rev | 2023 | 35751889 | PubTator, text mining | PubMed |
| On the modulation of TRPM channels: Current perspectives and anticancer therapeutic implications. | Front Oncol | 2022 | 36844925 | PubTator, text mining | PubMed |
| Immune cell-specific smoking-related expression characteristics are revealed by re-analysis of transcriptomes from the CEDAR cohort. | Cent Eur J Immunol | 2022 | 36817262 | PubTator, text mining | PubMed |
| Comparative transcriptome analysis of rainbow trout gonadal cells (RTG-2) infected with U and J genogroup infectious hematopoietic necrosis virus. | Front Microbiol | 2022 | 36733771 | PubTator, text mining | PubMed |
| Correlation between ITGB2 expression and clinical characterization of glioma and the prognostic significance of its methylation in low-grade glioma(LGG). | Front Endocrinol (Lausanne) | 2022 | 36714574 | PubTator, text mining | PubMed |
| Intestinal and blood lymphograms as new diagnostic tests for celiac disease. | Front Immunol | 2022 | 36713361 | PubTator, text mining | PubMed |
| Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis. | Front Genet | 2022 | 36712869 | PubTator, text mining | PubMed |
| Low expression of NR1H3 correlates with macrophage infiltration and indicates worse survival in breast cancer. | Front Genet | 2022 | 36699456 | PubTator, text mining | PubMed |
| Type 2 and type 17 effector cells are increased in the duodenal mucosa but not peripheral blood of patients with functional dyspepsia. | Front Immunol | 2022 | 36685573 | PubTator, text mining | PubMed |
| EccDNA-oriented ITGB7 expression in breast cancer. | Ann Transl Med | 2022 | 36660685 | PubTator, text mining | PubMed |
| High beta integrin expression is differentially associated with worsened pancreatic ductal adenocarcinoma outcomes. | Am J Cancer Res | 2022 | 36628277 | PubTator, text mining | PubMed |
| Examining the immune signatures of SARS-CoV-2 infection in pregnancy and the impact on neurodevelopment: Protocol of the SIGNATURE longitudinal study. | Front Pediatr | 2022 | 36619503 | PubTator, text mining | PubMed |
| Skin-homing basophils and beyond. | Front Immunol | 2022 | 36618424 | PubTator, text mining | PubMed |
| Dendritic Cell-Triggered Immune Activation Goes along with Provision of (Leukemia-Specific) Integrin Beta 7-Expressing Immune Cells and Improved Antileukemic Processes. | Int J Mol Sci | 2022 | 36613907 | PubTator, text mining | PubMed |
| Development of 89Zr-anti-CD103 PET imaging for non-invasive assessment of cancer reactive T cell infiltration. | J Immunother Cancer | 2022 | 36600560 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3695/papers?page=10